Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

Pfizer was among the 17 companies that received a July 31 letter from president Donald Trump demanding lower drug prices.

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing ...

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million ...

A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 vaccine. Long-term changes could have severe implications.